Medrx Co., Ltd.
株式会社メドレックス
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4586
FY2025 · 2025-12-31
| Gross margin | 99.1% |
| Operating margin | -735.5% |
| Net margin | -731.8% |
| Return on equity | -49.1% |
| Return on assets | -43.4% |
| Revenue growth (YoY) | -50.3% |
| EPS (basic) | ¥-17.44 |
| EPS growth (YoY) | — |
| Current ratio | 23.62x |
| Equity ratio | 88.6% |
| Book value / share | ¥33.51 |
| Free cash flow | -971 M |